1. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
   Amon Asgharpour et al, 2016, Journal of Hepatology CrossRef
2. Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets
   Manny D. Bacolod et al, 2015, null CrossRef
3. Syntenin controls migration, growth, proliferation, and cell cycle progression in cancer cells
   Rudra Kashyap et al, 2015, Frontiers in Pharmacology CrossRef
4. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
   Anjan K. Pradhan et al, 2023, Molecular Cancer Therapeutics CrossRef
5. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer
   Elisabeth Drucker et al, 2019, Cell Communication and Signaling CrossRef
6. Biological Role and Aberrant Overexpression of Syntenin-1 in Cancer: Potential Role as a Biomarker and Therapeutic Target
   Valeria Guadalupe Pintor-Romero et al, 2023, Biomedicines CrossRef
7. Syntenin overexpression in human lung cancer tissue and serum is associated with poor prognosis
   Pengyong Luo et al, 2020, BMC Cancer CrossRef
8. Tumor Microenvironment and Intracellular Signal-Activated Nanocomposites for Anticancer Drug Delivery
   Yilan Huang et al, 2021, Biomedical Composites CrossRef
9. The Genetic Architecture of Murine Glutathione Transferases
   Lu Lu et al, 2016, PLOS ONE CrossRef
10. Endogenous Stimuli-responsive Nanocarriers for Drug Delivery
    Huachao Chen et al, 2016, Chemistry Letters CrossRef
11. Identification of chromatin‐accessible domains in non‐alcoholic steatohepatitis‐derived hepatocellular carcinoma
    Mekonnen L. Dechassa et al, 2018, Molecular Carcinogenesis CrossRef
12. Nanotechnological strategies involved in the targeted delivery of anticancer drugs
    Muhammad Raza Shah et al, 2019, Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy CrossRef
13. Comparative Proteomics Analysis of Exosomes Identifies Key Pathways and Protein Markers Related to Breast Cancer Metastasis
    Shichen Shen et al, 2023, International Journal of Molecular Sciences CrossRef
14. Syntenin1/MDA-9 (SDCBP) induces immune evasion in triple-negative breast cancer by upregulating PD-L1
    Jing Liu et al, 2018, Breast Cancer Research and Treatment CrossRef
15. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer
    Mitchell E. Menezes et al, 2016, Oncotarget CrossRef
16. The Multifunctional Protein Syntenin-1: Regulator of Exosome Biogenesis, Cellular Function, and Tumor Progression
    Kwang-Min Lee et al, 2023, International Journal of Molecular Sciences CrossRef
17. MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis
    Swadesh K. Das et al, 2019, null CrossRef
18. MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein
    Anjan K. Pradhan et al, 2020, Cancer and Metastasis Reviews CrossRef